Left Brain Wealth Management LLC Buys New Shares in CME Group Inc. $CME

Left Brain Wealth Management LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 11,533 shares of the financial services provider’s stock, valued at approximately $3,179,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Webster Bank N. A. grew its holdings in shares of CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares in the last quarter. Highline Wealth Partners LLC lifted its position in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the period. Ransom Advisory Ltd acquired a new stake in CME Group during the first quarter worth $31,000. Trifecta Capital Advisors LLC increased its holdings in CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after buying an additional 42 shares during the period. Finally, Westside Investment Management Inc. raised its stake in shares of CME Group by 105.0% in the 2nd quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock valued at $34,000 after buying an additional 63 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Down 0.8%

Shares of CME opened at $273.09 on Friday. The company has a market capitalization of $98.48 billion, a P/E ratio of 26.46, a PEG ratio of 4.41 and a beta of 0.38. CME Group Inc. has a one year low of $224.62 and a one year high of $290.79. The business’s 50 day simple moving average is $268.74 and its 200-day simple moving average is $272.70. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.68 EPS. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be given a dividend of $1.25 per share. The ex-dividend date is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio is 48.45%.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Barclays decreased their target price on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 8th. Keefe, Bruyette & Woods lifted their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Raymond James Financial dropped their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a report on Monday, October 13th. Rothschild & Co Redburn raised their target price on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a research report on Thursday, November 6th. Finally, Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Eight research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus target price of $287.65.

Insider Activity

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This represents a 3.83% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the transaction, the director owned 1,091 shares in the company, valued at $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 14,043 shares of company stock worth $3,791,486. 0.30% of the stock is currently owned by insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.